DARS2 and hepatocellular carcinoma: Our results showed that HBV suppressed NFAT5 expression by inducing hypermethylation of the AP1-binding site in the NFAT5 promoter and inhibiting miR-30e-5p/MAP4K4/DARS2 pathway in hepatoma cells.